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SUMMARY  
 
Exposure reduction to exhaled air from a sick doctor wearing personal exhaust unit 
incorporated in headset-microphone was studied. Experiments were performed in a full-scale 
test room furnished as a double-bed hospital room with overhead ventilation at 3, 6 and 12 
ACH. Room air temperature was 22 °C. Breathing thermal manikin with realistic body and 
breathing cycle was used to mimic doctor. Second thermal manikin and heated dummy were 
used to resemble lying patients. Exhaled air by the doctor was mixed with tracer gas to mimic 
pathogens. The unit was positioned frontally by the mouth of the doctor at three different 
distances. It was operated at 0.25 or 0.50 L/s under mixing background ventilation at 3 ACH. 
The use of wearable personal exhaust resulted in cleaner air in the room compared to mixing 
alone at 12 ACH. The high potential to capture exhaled air makes the device efficient against 
airborne pathogens. 
 
INTRODUCTION 
 
Hospital ventilation systems should be designed differently from communal ventilation, as in 
the former case the main sources of contamination (pathogens) are released indoors. Hence 
conventional methods for filtering or cleaning the air will not be efficient (Bolashikov et al. 
2009). Elevated ventilation rates exceeding 6 ACH and up to 20 ACH are recommended in 
hospitals, AIA (2001), CDC (2003) and ASHRAE/ASHE 170 (2008). Elevated ventilation 
rates brings the following drawbacks: 1) significantly increased energy consumption in air 
handling and transport; 2) increased investment and maintenance costs in hospitals due to 
oversized HVAC systems and large unoccupied spaces to facilitate them; 3) elevated risk 
from thermal discomfort for occupants. The entire volume of space is ventilated without 
considering the pathogen infectivity and the number of infective sources present. Hence 
spaces are under-ventilated with respect to generated airborne pollution in the room. 
 
An efficient way to evacuate the respiratory (breathing, coughing) generated pathogens indoor 
is to capture them close to source origin, i.e. near the breathing zone of the sick occupant. 
Incorporating localized exhaust at the hospital bed at the head sides can ensure efficient 
extraction of exhaled air by sick individuals. This will reduce the airborne pathogen spread 
indoors at greatly reduced ventilation rates, Bolashikov (2010), Melikov et al. (2010) and 
Melikov et al. (2011). However this method will work as long as the sick occupant stays lying 
in bed. Medical staff or visitors can be sick and can release airborne pathogens with 
exhaled/coughed air. In this case the bed incorporated ventilation will not work in reducing 
the airborne spread in the surroundings. A local exhaust orifice aesthetically incorporated into 
the mouthpiece of a headset could be used. It will capture the expired air directly within the 
breathing zone of the occupant. The captured air can be then cleansed and filtered via a 
portable unit attached to the clothing of the user. The concept of using headset microphone 
incorporated personalized ventilation (PV) is not new. Such wearable PV was used to supply 
clean air directly into the breathing zone of the occupant with great efficiency at flow rates 
lower than 0.5 L/s, Bolashikov et al. (2003), Kaczmarczyk et al. (2006), Zhu et al. (2008) and 
Bolashikov (2010). However, using the PV device to extract locally the respired air has not 
yet been investigated. 
 
In this paper results are presented showing the potential of wearable exhaust PV unit used by 
infected doctor to reduce the level of exposure for patients in a double bed hospital room. 
 
METHODOLOGIES  
 
Experiments were designed and performed in a climate chamber with dimensions 4.75 m x 
4.65 m x 2.60 m (W x L x H) furnished to simulate double-bed hospital room. The distance 
between the beds was set to 1.3 m, Figure 1. Five ceiling-mounted light fixtures (6 W each) 
provided the background lighting. The chamber was located in a larger hall, where the 
temperature was kept constant and equal to the air temperature in the test room. A dressed 
breathing thermal manikin (1.02 Clo) with realistic body geometry and surface temperature 
distribution was used to resemble a “infected doctor” standing next to one of the two beds: 
0.55 m away, Melikov and Kaczmarczyk (2007). The doctor was facing the patient. The 
manikin consisted of 17 sections. The manikin was equipped with artificial lung to simulate 
breathing sick doctor. One full breathing cycle consisted of inhalation – 2.5 s, exhalation – 2.5 
s and break – 1 s. The characteristics of the breathing cycle were: inhalation nose, exhalation 
mouth with tidal flow rate of 0.24 L/s (6 L/min), Hyldgaard (1994). A second thermal 
manikin of 23 body segments was used to simulate sick patient lying in one of the beds 
closest to the doctor. The manikin was dressed with hospital gowns of 0.38 Clo. Each manikin 
released on average 60 W sensible heat. A heated dummy with simplified body geometry was 
used to mimic the second patient lying in the other bed. It released also around 60 W of heat. 
The two beds were placed in parallel and both patients were facing the ceiling, Figure 1. 
During all experiments overhead mixing ventilation was used. The supply air was 100% 
outdoor air. The supply diffuser was a solid face plate square diffuser and a 3-way-discharge. 
Two square ceiling mounted diffusers with perforated face plate were used to exhaust the air 
from the room. They were installed above the heads of the two patients. The exhausted air 
was equally balanced between the two diffusers.   
 
For the purpose of the experiment the headset incorporated wearable exhaust PV (WEPV) was 
simplified to test the effectiveness of capturing the contaminated exhaled air: a circular 
exhaust nozzle (d = 0.03 m) attached to a flexible pipe and positioned on a stand in front of 
the doctor’s mouth, Figure 2. The WEPV was connected to a separate ventilation system 
consisting of flexible pipe, reduction, 2 dampers, 2 iris orifices and a fan. The exhaust flow 
rate through the nozzle was 0.25 L/s or 0.5 L/s. The dumpers, the orifices and the fan were 
located outside the climate chamber, within the tall hall. The exhaled air captured by the 
WEPV was exhausted into the exhaust of the tall hall not to contaminate the surroundings. 
The experiments without the headset device were performed at 3, 6 and 12 ACH. During the 
experiments with the headset the background ventilation in the chamber was kept at 3 ACH. 
The headset was positioned either 0.02 or 0.04 or 0.06 m from the mouth of the doctor, Figure 
2c. Room air temperature was kept at 22˚C, while the relative humidity was not controlled but 
was measured to vary between 30% and 40% during all conditions. Air temperature and flow 
rate of supplied and exhausted air, air temperature inside the test room and the amount of air 
exhausted by the WEPV were constantly recorded and controlled to keep the set values. 
 
 
Figure 1.  Experimental set-up and locations of the sampling points for the tracer gas 
concentration measurements; top view: I- exposed patient 1(EP1), II- exposed patient 2(EP2), 
1 – supply, 2 – exhaust over EP1, 3 – exhaust over EP2, 4 – mouth of EP1, 5 – mouth of EP2, 
6 – centre of the room 1.7 m above the floor, 7 – centre of the room 1.1 m above the floor, 8 – 
centre of the room 0.1 m above the room, 9 –left from EP2 1.7 m above the floor, 10 – at feet 
of EP1 1.7 m above the floor, 11 – at feet of EP1 1.1 m above the floor, 12 – WEPV exhaust. 
 
  
  
a) 
 
b)  c) 
Figure 2.  Headset incorporated wearable PV exhaust: a) conceptual design, b) tested nozzle 
geometry, c) simplified design 
 
During all experiments R 134a tracer gas was used. It was dosed in the air exhaled by the 
breathing thermal manikin used to simulate the sick doctor. The dozed tracer gas was kept the 
same for all tested cases, i.e. 4.2 mg/s. The tracer gas was used to simulate airborne droplets 
and droplet nuclei of less than 3 µm aerodynamic diameter, Camargo-Valero et al. (2011) and 
Li et al. (2014), that may carry one or many pathogens. The exhaled air from the manikin 
(doctor) was also heated to ensure a density close to that of air exhaled by a human being. In 
order to avoid transport of tracer gas (R 134a) from the surrounding hall, in case of gas 
leakage from gas bottle, the experimental chamber was kept over-pressurized at 1.6±0.2 Pa. 
The tracer gas concentration was measured with two sets of multi gas sampler and analyzer 
based on the photo acoustic principle at 12 points, Figure 1: 1) in ventilation supply, 2) in 
exhaust over exposed patient 1 (EP1), 3) in exhaust over the exposed patient 2 (EP2), 4) at 
the mouth of EP1, 5) at the mouth of EP2, 6) at the centre of the room 1.7 m above the floor, 
7) at the centre of the room 1.1 m above the floor, 8) at the centre of the room 0.1 m above the 
floor, 9) left from EP2 (0.55 m distance from the mouth) 1.7 m above the floor, 10) close to 
the feet of EP1 at 1.7 m above the floor, 11) close to the feet of EP1 at 1.1 m above the floor. 
The twelfth measurement point was for measuring the concentration in the air exhausted by 
the headset. Therefore this point was used for the conditions that included the headset device. 
Neither the manikin simulating EP1 nor the heated dummy (EP2) were breathing. The 
sampling tube of R 134a was placed at the mouth 0.005 m away. As reported in the literature 
the tracer gas concentration measured in this way is equal to the tracer gas concentration in 
the air inhaled by the breathing thermal manikin, Melikov and Kaczmarczyk (2007). 
 
Experimental Procedure 
 
At the start of the experiments both thermal manikins and the dummy were switched on. For 
the experiments with headset the device was positioned in front of the mouth of the doctor at 
any of the three tested distances and the system exhausting the exhaled air was adjusted to the 
tested air flow rate. All measurements commenced after steady-state conditions were 
achieved, i.e. steady tracer concentrations at the centre of room and in both TV exhausts 
(located at the ceiling) measurement locations. After reaching a steady state, 15 samples for 
each measurement point were acquired.  
 
Analyses of Results 
 
The obtained tracer gas concentration data were normalized (ɛ) according to the following 
equation: 
 
ɛ = (Cm – Cs)/(Cm(3ACH) – Cs(3ACH)) 
    
,where ɛ is normalized concentration (evacuation effectiveness), Cm is concentration acquired 
in the measuring location, Cs is concentration acquired in total volume ventilation supply, 
Cm(3ACH) – concentration in the measuring point at 3ACH (without headset) and Cs(3ACH) 
is concentration in the total volume ventilation supply at 3ACH (without headset). This in fact 
presents the evacuation performance of the WEPV unit or dilution efficiency (in the cases of 
mixing ventilation alone at 6 and 12 ACH) relative to the pollutant dilution in the room when 
ventilated at 3 ACH and no source control applied. A value of 1 means that the evacuation 
effectiveness was like the dilution provided by mixing ventilation operated at 3 ACH. The 
lower the value than 1 the better the performance of the ventilation system with respect to 
pollutant evacuation is. 
RESULTS AND DISCUSSION 
 
The measured concentration of R 134a tracer gas and its normalized value are presented in 
Figure 3 and Figure 4. The following abbreviations are used in the legend of Figure 3 and 
Figure 4: ACH: air changes per hour, W/O: without, HS: headset (WEPV). The abbreviations 
used to code the studied cases should be read as follows: 1st is the background ventilation 
level in the room, 2nd comes the presence or absence of headset within the breathing zone of 
the occupant, 3rd is the exhaust air flow of the WEPV unit tested and last, i.e. 4th, is the 
distance the unit was positioned from the mouth of the occupant (thermal manikin). For 
example the abbreviation 3 ACH_HS 0.25 L/s_0.02 m should be understood as: background 
room ventilation is at 3 ACH, the doctor is wearing the headset (WEPV), which exhausts 0.25 
L /s and is located at 0.02 m away from the doctor’s mouth.  
 
As can be seen from Figure 3 exhausting 0.25 L/s locally by the WEPV helped reduce the 
spread of exhaled air from the doctor into the room. Increasing the distance between the 
doctor’s moth and the nozzle resulted in increase of the normalized concentration, i.e. 
decrease in evacuation effectiveness. The best performance at this exhaust flow rate of 0.25 
L/s was when the WEPV was placed 0.02 m from the mouth of the doctor. At this case the 
evacuation performance of the WEPV unit was even better compared to the dilution provided 
by the total volume ventilation operated alone at 12 ACH. When the doctor was with the 
WEPV the normalized concentration in all measured locations, but at the feet of EP1, at 1.7 m 
above the floor, was lower compared to the case when the room was ventilated at 12 ACH 
and the device was not used. When the WEPV was set 0.04 m from the mouth of the doctor its 
evacuation performance was still better compared to total volume ventilation alone at 6 ACH. 
Similarly to the case when the WEPV was 0.02 m away from the doctor’s mouth the highest 
normalized concentration of exhaled air was measured at the feet of EP1 at 1.7 m above the 
floor. This trend was also noticed when the WEPV was 0.04 m from the mouth of the doctor. 
Apparently the airflow pattern in the room pushes the pollutants towards the feet of the 
patients: 3-way supply diffuser. This needs to be further studied.  
 
 
Figure 3. Normalized concentration, when the doctor was without or with the WEPV 
exhausting at 0.25 L/s and positioned 0.02, 0.04 or 0.06 m distance from doctor’s mouth.  
 
Comparison of the evacuation effectiveness of the unit when exhausting at 0.50 L/s is shown 
in Figure 4. The distance at which the WEPV was placed from the mouth affected its 
performance. The further the WEPV was moved from the mouth the lower the evacuation 
performance was. At the closest distance of 0.02 m the WEPV was evacuating the exhaled air 
better compared to the dilution provided by the total volume ventilation when operated at 12 
ACH. However at the mouth of EP1, the patient whose bed was closest to doctor, the 
normalized concentration was higher for the case 3 ACH_HS 0.50 L/s_0.02 m compared to 12 
ACH_W/O HS. It is well known that the velocity distribution across exhaust opening is not 
uniform and is influenced by wake formations near the rim of the nozzle resulting in pulling 
background room air as well, Awbi (2003). The exhaust flow pulled more room air at the 
WEPV nozzle rim, which resulted in less exhaled air captured. Also the normalized 
concentration at the feet of EP1 at 1.7 m above the floor was slightly higher compared to 
mixing alone at 12 ACH, Figure 4. Again the airflow pattern in the room might have pushed 
the pollutants towards the feet of the patients. This needs to be further studied. 
 
 
Figure 4. Normalized concentration, when the doctor was without or with the WEPV 
exhausting at 0.50 L/s and positioned 0.02, 0.04 or 0.06 m distance from doctor’s mouth. 
 
WEPV was performing slightly better when exhausting 0.25 L/s compared to 0.50 L/s at all 
measured locations, Figure 5. This again can be explained by the fact that under the increased 
exhaust flow the WEPV pulled more room air on the nozzle sides resulting in less exhaled air 
captured. This can also be seen in the tracer gas concentration measured in the air captured by 
the WEPV, Figure 6. As can be noticed the concentration of R 134a when WEPV positioned at 
0.04 and 0.02 m and was exhausting 0.25 L/s was higher than when it was exhausting 0.05 
L/s suggesting less dilution with room air. The WEPV unit shows great potential at reducing 
the spread of pathogen laden air indoors. The present paper shows that applying local control, 
i.e. exhausting expired air within the breathing zone, can result in significantly reduced spread 
of infected exhaled air in hospital wards. This will result in lowered exposure of occupants to 
airborne pathogens and decreased supply of background air to dilute the room air. For the 
measurement with the headset the mixing ventilation was operated at 3 ACH. The use of the 
headset device showed that the background concentration in the measured locations was 
lowered to that at 12 ACH background ventilation and without the headset. It is important to 
be note that the nozzle for this condition was placed 0.02 m away from the doctor’s mouth, 
typical position of a headset microphone piece.  
 
Previous research on the headset PV showed that the device is also very efficient in supplying 
clean air into the inhalation Bolashikov et al. (2003), Zhu et al. (2008) and Bolashikov (2010). 
In practice, the headset can be made with a micro-pump (reversible to supply or exhaust the 
air) enclosed in a small casing with a mini-filter and mini-UVGI (ultra violet germicidal 
irradiation). The box can be worn attached to a belt around the waist of the user. The pump 
can be reversed and can start exhausting the exhaled air. Obviously further improvements in 
the design and airflow direction control of the headset are needed in order to be comfortable 
and not disturbing for wearing. Its small dimensions and simplicity will allow its application 
not only in hospital environment but in many densely occupied spaces: at reception desks, 
auditoriums, public transport services, airplanes, etc. 
 
 
Figure 5. Normalized concentration when WEPV was exhausting 0.25 L/s and 0.50 L/s and 
was positioned 0.02, 0.04 or 0.06 m distance from doctor’s mouth. 
 
 
Figure 6. Tracer gas concentration measured at the exhaust of the headset WEPV under the 
two exhaust flows. 
 
CONCLUSIONS 
 
The present study focused on the reduction in exposure to exhaled air by a “sick” doctor 
wearing headset incorporated exhaust device (WEPV) in a simulated double bed hospital 
room ventilated by mixing air distribution.  
• The use of the headset exhaust device at 3 ACH background ventilation rate reduced 
the exposure of the patients as well as the background tracer gas concentration; the 
reduction was higher at suction flow rate of 0.25 L/s than at 0.50 L/s;  
• The increase of the distance of the device from the mouth from 0.02 m to 0.06 m 
reduced its ability to evacuate the exhaled air (evacuation effectiveness);  
• When the WEPV was 0.02 m from the doctors mouth it reduced the spread of exhaled 
air better than the dilution provided by mixing ventilation at 12 ACH for both exhaust 
flows tested of 0.25 and 0.50 L/s; 
• Similarly, when the WEPV was 0.04 m from the doctors mouth it reduced the spread 
of exhaled air better than the dilution provided by mixing ventilation at 6 ACH for 
both exhaust flows tested of 0.25 and 0.50 L/s; 
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